Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

JNK Inhibitor VIII (CAS 894804-07-0)

5.0(1)
Write a reviewAsk a question

See product citations (2)

Alternate Names:
N-(4-Amino-5-cyano-6-ethoxypyridin-2-yl)-2-(2,5-dimethoxyphenyl)acetamide
Application:
JNK Inhibitor VIII is an inhibitor shown to suppress apoptosis, caspase cleavage, and cytochrome C release
CAS Number:
894804-07-0
Purity:
≥95%
Molecular Weight:
356.37
Molecular Formula:
C18H20N4O4
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

JNK inhibitor VIII is an inhibitor of c-Jun N-terminal kinases (JNK) that has been reported to suppress apoptosis, caspase cleavage, and cytochrome C release. Studies indicate that the inhibitor can block the phosphorylation of JNK without affecting the expression of IL-6, IL-8, or COX-2. JNK activity studies demonstrate that JNK Inhibitor VIII inhibits the phosphorylation of JNKAR1 and response to anisomycin (sc-3524). Additionally, JNK Inhibitor VIII has been noted to reduce TGF-induced JNK activation. It is also an inhibitor of JNK1, JNK2 and JNK3.


JNK Inhibitor VIII (CAS 894804-07-0) References

  1. Aminopyridine-based c-Jun N-terminal kinase inhibitors with cellular activity and minimal cross-kinase activity.  |  Szczepankiewicz, BG., et al. 2006. J Med Chem. 49: 3563-80. PMID: 16759099
  2. Activation of c-Jun N-terminal kinase is essential for oxidative stress-induced Jurkat cell apoptosis by monochloramine.  |  Ogino, T., et al. 2009. Leuk Res. 33: 151-8. PMID: 18718660
  3. Modulation of hepatic fibrosis by c-Jun-N-terminal kinase inhibition.  |  Kluwe, J., et al. 2010. Gastroenterology. 138: 347-59. PMID: 19782079
  4. Mitogen-activated protein kinase phosphatase-1 negatively regulates the expression of interleukin-6, interleukin-8, and cyclooxygenase-2 in A549 human lung epithelial cells.  |  Turpeinen, T., et al. 2010. J Pharmacol Exp Ther. 333: 310-8. PMID: 20089808
  5. Visualization of JNK activity dynamics with a genetically encoded fluorescent biosensor.  |  Fosbrink, M., et al. 2010. Proc Natl Acad Sci U S A. 107: 5459-64. PMID: 20212108
  6. A vaccinia virus-driven interplay between the MKK4/7-JNK1/2 pathway and cytoskeleton reorganization.  |  Pereira, AC., et al. 2012. J Virol. 86: 172-84. PMID: 22031940
  7. The expression of interleukin-12 is increased by MAP kinase phosphatase-1 through a mechanism related to interferon regulatory factor 1.  |  Korhonen, R., et al. 2012. Mol Immunol. 51: 219-26. PMID: 22464096
  8. Identification and characterization of bi-thiazole-2,2'-diamines as kinase inhibitory scaffolds.  |  Ngoei, KR., et al. 2013. Biochim Biophys Acta. 1834: 1077-88. PMID: 23410953
  9. A novel retro-inverso peptide is a preferential JNK substrate-competitive inhibitor.  |  Ngoei, KR., et al. 2013. Int J Biochem Cell Biol. 45: 1939-50. PMID: 23792175
  10. MEK/ERK activation plays a decisive role in yellow fever virus replication: implication as an antiviral therapeutic target.  |  Albarnaz, JD., et al. 2014. Antiviral Res. 111: 82-92. PMID: 25241249
  11. The effects of short-term JNK inhibition on the survival and growth of aged sympathetic neurons.  |  Guha, I., et al. 2016. Neurobiol Aging. 46: 138-48. PMID: 27490965
  12. FOSB⁻PCDHB13 Axis Disrupts the Microtubule Network in Non-Small Cell Lung Cancer.  |  Ting, CH., et al. 2019. Cancers (Basel). 11: PMID: 30658436
  13. The small molecule AZD6244 inhibits dengue virus replication in vitro and protects against lethal challenge in a mouse model.  |  de Oliveira, LC., et al. 2020. Arch Virol. 165: 671-681. PMID: 31942645
  14. Endoplasmic reticulum stress causes insulin resistance by inhibiting delivery of newly synthesized insulin receptors to the cell surface.  |  Brown, M., et al. 2020. Mol Biol Cell. 31: 2597-2629. PMID: 32877278

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

JNK Inhibitor VIII, 5 mg

sc-202673
5 mg
$267.00